95% CI	95% Confidence Interval
BC	Breast Cancer
BMI	Body Mass Index
CDK4/6	Cyclin-Dependent Kinase 4/6 Inhibitors
c-Fos	Proto-oncogene c-Fos
DFS	Disease-Free Survival
DPP-4	Dipeptidyl Peptidase 4
GI	Gastrointestinal
GIP	Glucose-Dependent Insulinotropic Polypeptide
GLP-1	Glucagon-Like Peptide-1
GLP-1 RAs	GLP-1 Receptor Agonists
HbA1c	Hemoglobin A1c
HR	Hazard Ratio
IGFs	Insulin-Like Growth Factors
IL-6	Interleukin 6
JAK/STAT	Janus Kinase/Signal Transducer and Activator of Transcription
MAPK	Mitogen-Activated Protein Kinase
MEN2	Multiple Endocrine Neoplasia Syndrome type 2
mTOR	Mammalian Target of Rapamycin
NAFLD	Nonalcoholic Fatty Liver Disease
OS	Overall Survival
PI3K/Akt	Phosphatidylinositol 3-Kinase/Protein Kinase B
RCTs	Randomized Controlled Trials
SERMs	Selective Estrogen Receptor Modulators
T2DM	Type 2 Diabetes Mellitus
TNF-α	Tumor Necrosis Factor Alpha